Document is current

Any future updates will be listed below

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

Crossref DOI link: https://doi.org/10.1186/s12876-017-0694-6

Published Online: 2017-11-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark